Latest News

More Articles

Mirae Asset Expands AI-Themed ETF Offerings with Launch of Global X AI Infrastructure ETF

- The new Global X AI Infrastructure ETF (3401)brings Mirae Asset\'s AI-themed lineup to six products,offering both active and passive strategies for comprehensive investment solutions.

Feb 11, 2025

iQIYI sees surge in viewership during Chinese New Year: users favor classic IPs, long and short content, and strong interaction

BEIJING,Feb. 7,2025--On Feb. 5,iQIYI,China\'s leading online entertainment platform,released its viewership data and content trends for the Chinese New Year (CNY) holiday period (Jan. 28 to Feb. 4).

Feb 10, 2025

CGTN: China's booming ice and snow industry fuels its economic growth

BEIJING,Feb. 7,2025-- Harbin,capital of northeast China\'s Heilongjiang Province,exemplifies the country\'s thriving ice and snow economy.

Feb 10, 2025

Datasea Pre-Announces Second Quarter Revenue of $20.5 Million, up 81% Year-over-Year

Gross Profit achieved a 310% Increase Year-over-Year BEIJING,Feb. 5,2025-- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or "the Company"),a Nevada-based digital technology company speci

Feb 7, 2025

Amadeus and Traveloka strengthen travel technology partnership

SINGAPORE,Feb. 6,2025-- Amadeus,the leading global travel technology company,has strengthened its partnership with Traveloka,Southeast Asia\'s top travel platform. This agreement sees Amadeus\' alread

Feb 7, 2025

Akeso Announces the Completion of Patient Enrollment in the Phase III Clinical Trial (HARMONi-6) Comparing Ivonescimab and Tislelizumab for First-Line Treatment of Sq-NSCLC

HONG KONG,Feb. 6,2025--Akeso,Inc. (9926.HK) ("Akeso" or the "Company")is excited to announce the completion of patient enrollment in the global Phase III clinical trial (HARMONi-6/

Feb 7, 2025

Argent BioPharma: A Hidden Gem traded Under $12M--Edison Group Report Assigned a $327M Valuation to Its Breakthrough Epilepsy Treatment

PERTH,Australia,Feb. 6,2025-- Argent BioPharma (ASX: RGT) (OTCQB: RGTLF),a clinical-stage biopharmaceutical company brings hope to epilepsy patients.

Feb 7, 2025

Dubai Fountain Undergoes a Stunning Revamp: Temporary Closure Announced for Upgrade and Enhancement

Starting in May,the iconic attraction will be closed for five months DUBAI,UAE,Feb. 6,2025-- Emaar has announced the temporary closure of Dubai Fountain,the world\'s largest performing fountain,locate

Feb 7, 2025

NetEase to Report Fourth Quarter and Fiscal Year 2024 Financial Results on February 20

HANGZHOU,China,Feb. 6,2025-- NetEase,Inc. (NASDAQ: NTES and HKEX: 9999,"NetEase" or the "Company"),a leading internet and game services provider,today announced that it will report

Feb 7, 2025

Cellid Raises $13 Million to Advance AR Glasses Display Development

Advancing Adoption through Enhanced Mass Production and Accelerated Product Launches TOKYO,Feb. 6,2025-- Cellid Inc.,a developer of AR glasses displays and spatial recognition engines for next-genera

Feb 7, 2025

Arcadium Lithium Announces Date for Fourth Quarter and Full Year 2024 Earnings Release

PHILADELPHIA and PERTH,Australia,Feb. 7,2025-- Arcadium Lithium plc (NYSE: ALTM,ASX: LTM,"Arcadium Lithium") today announced it will release fourth quarter and full year 2024 earnings resul

Feb 7, 2025

BRI UMKM EXPO(RT) 2025 Returns: Showcasing Local Products to the World

JAKARTA,Indonesia,Jan. 25,2025--PT Bank Rakyat Indonesia (Persero) Tbk (IDX: BBRI)is hosting the 6th edition of BRI UMKM EXPO(RT) 2025 (previously known as UMKM EXPO(RT) BRILIANPRENEUR),is a testament

Feb 6, 2025

1 ... 30 31 32 33 34 35 36 ... 116

Voice Of Zimbabwe: Your Source for Tech, AI, Aerospace, Biotech News

Voice Of Zimbabwe, a technology news portal in Europe and the United States. Dedicated to reporting the latest developments in technology, artificial intelligence, biotechnology, data and other fields.